IMM 5.95% 44.5¢ immutep limited

Media, page-13

  1. 5,161 Posts.
    lightbulb Created with Sketch. 1626
    On Aug 24th they they changed the completion date from Aug 10 to Aug 31 ... so, they may have been anticipating the patent approval. It may be obvious to some but one may still ask the question, if this postponement of completion (by weeks, days) is related to the anticipation of patent approval (?)

    Here are some dates and patients anticipated at the time ...

    Jan 2018, 126(anticipated)
    July 2018, 96(anticipated)
    June 2019, 84(anticipated)
    Jan 2020, 88(Actual - Stopped recruiting - likely due to covid (?) )
    Study completion date has been pushed back a number of times from initial Oct 2020 to Aug 2021. This is likely a good thing - because it means the study was continuing and no serious adverse effect was observed or significant to report which in trials terms is good news meaning those who are surviving are doing ok .... perhaps. I hope! So, it is all about numbers when they come out and I have a feeling they will be out soon-ish ... perhaps. I hope!

    For those who are not familiar with trials: recruitment usually finishes quite some time before the completion of study. This is to allow following up on the last patient recruited for a set period of time. For this trial: 24 months (primary outcome) and 3 years (for secondary outcome).



 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
44.5¢
Change
0.025(5.95%)
Mkt cap ! $529.0M
Open High Low Value Volume
42.0¢ 45.0¢ 42.0¢ $1.157M 2.651M

Buyers (Bids)

No. Vol. Price($)
2 98121 44.5¢
 

Sellers (Offers)

Price($) Vol. No.
45.0¢ 349969 10
View Market Depth
Last trade - 16.10pm 29/04/2024 (20 minute delay) ?
Last
45.0¢
  Change
0.025 ( 6.71 %)
Open High Low Volume
42.5¢ 45.0¢ 42.0¢ 744716
Last updated 15.59pm 29/04/2024 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.